Latest News

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Influenza, St. Jude Children's Research Hospital, Vaccine, Leukemia, Flu Shot, Acute Lymphoblastic Leukemia

Flu Vaccine Failed to Protect Young Leukemia Patients During Cancer Treatment

St. Jude Children’s Research Hospital investigators said the results reinforce the importance of hand washing and other measures to help protect vulnerable patients from influenza infections.

Medicine

Channels:

Fertility, Childhood Cancer Survivor, sperm banking, Oncofertility, Infertility, Infertility Patients, Journal Of Clinical Oncology

Sperm Banking Is Underutilized by Adolescent and Young Adult Cancer Patients

00194853-014.jpg

Research led by St. Jude Children’s Research Hospital found meeting with fertility specialists and parental recommendations play key roles in decisions at-risk male cancer patients make about fertility preservation

Medicine

Channels:

Levofloxacin, acute lymphoblastic leukemia (ALL) , Antibacterial, Prophylaxis, leukemia treatment, Antibiotic Therapy, Infection Control

Antibiotic Identified That Reduces Infection Risk in Young Leukemia Patients

00195242-014.jpg

St. Jude Children’s Research Hospital investigators report preventive antibiotic therapy, particularly with levofloxacin, reduced the odds of infections in at-risk pediatric leukemia patients early in cancer treatment

Medicine

Channels:

St. Jude Children's Research Hospital, St. Jude LIFE , late effects of cancer, Pediatric Cancer, Lancet, Childhood Cancer Survivor, Childhood Cancer Awareness Month, Epidemiology, Public Health, Health Care Delivery, Home Care

Comprehensive Study of Chronic Disease Reveals Vulnerability of Childhood Cancer Survivors

St. Jude Children’s Research Hospital analysis captures complexity and severity of chronic disease in childhood cancer survivors and suggests this growing population may benefit from more specialized health care delivery

Medicine

Channels:

St. Jude Children's Research Hospital, Childhood Solid Tumor Network, Solid Tumor Oncology, Michael Dyer, Developmental Biology, Orthotopic, xenografts, pediatric tumor

St. Jude Unveils Powerful Resource to Advance Treatment of Pediatric Solid Tumors

Dyer1.jpg

St. Jude Children’s Research Hospital is offering the global scientific community no-cost access to an unprecedented collection of pediatric solid tumor samples and data to fuel research and move treatment forward

Medicine

Channels:

St. Jude Children's Research Hospital, Childhood Cancer Survivor, HPV, Human Papilloma Virus, Vaccination Rate, Vaccination Compliance, James Klosky, University of Alabama at Birmingham, Journal Of Clinical Oncology

HPV Vaccination Rates Lag for Vulnerable Population of Childhood Cancer Survivors

Research suggests health providers are key to boosting HPV vaccination rates of childhood cancer survivors, who, as a group, are at increased risk for second cancers associated with the human papillomavirus.

Medicine

Channels:

St. Jude Children's Research Hospital, Hongbo Chi, Immunology, T Cell, T cell exhaustion, Allergy, Immune Response

Allergies? Exhausted Regulatory T Cells May Play a Role

00194896-010.jpg

Research led by St. Jude Children’s Research Hospital highlights the importance of immune cell metabolism for maintaining a balanced immune response.

Medicine

Channels:

St. Jude Children's Research Hospital, J. Paul Taylor, Neuron, ALS, Lou Gehrig's Disease, , frontotemporal dementia , Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, phase separation, ALS treatment

Researchers Discover Fundamental Pathology Behind ALS

00177033-011.jpg

A team led by scientists at St. Jude Children’s Research Hospital and Mayo Clinic has identified a basic biological mechanism that kills neurons in amyotrophic lateral sclerosis (ALS) and in a related genetic disorder, frontotemporal dementia (FTD), found in some ALS patients. ALS is popularly known as Lou Gehrig’s disease. The researchers were led by J. Paul Taylor, M.D., Ph.D., chair of the St. Jude Cell and Molecular Biology Department and a Howard Hughes Medical Institute investigator; and Rosa Rademakers, Ph.D., of the Mayo Clinic in Jacksonville, Florida. The findings appear today in the journal Neuron.

Medicine

Channels:

John Schuetz, St. Jude Children's Research Hospital, Pharmaceutical Science, AML, Acute Myeloid Leukemia, heme synthesis, HEME, JCI Insight, MYCN, UROD

Discovery Points to Drugs That Would ‘Short-Circuit’ Deadly Leukemia

St. Jude Children’s Research Hospital scientists have found that cells of a deadly acute myeloid leukemia can be killed by blocking production of a molecular “battery.”

Medicine

Channels:

St. Jude Children's Research Hospital, Immunology, Influenza, Influenza Infection, high-risk influenza, IFITM3 proteins, Anti-viral, Immune Response

Newly Identified Genetic Marker May Help Detect High-Risk Flu Patients

00194103-006.jpg

Researchers led by St. Jude Children’s Research Hospital have identified a genetic variation associated with influenza severity and the supply of killer T cells that help patients fight the infection.







Chat now!